Trial Details
Not recruitingBasic Information
| Clinical ID | c3030 |
|---|---|
| Identifier | NCT02351635 |
| Trial Title | Clinical Study of the BLMANN fCALELISA as an Aid in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease;Irritable Bowel Syndrome |
| Interventions | Other: fecal calprotectin level |
Participant Information
| Sponsor | Blmann Laboratories AG |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |